Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,727 | 355 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,962 | 80 | $0 (2024) |
| PFIZER INC. | $786.70 | 56 | $0 (2024) |
| Novo Nordisk Inc | $640.53 | 28 | $0 (2024) |
| Lilly USA, LLC | $597.56 | 38 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $466.40 | 17 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $369.70 | 15 | $0 (2021) |
| GlaxoSmithKline, LLC. | $341.49 | 24 | $0 (2024) |
| Merck Sharp & Dohme LLC | $169.82 | 11 | $0 (2024) |
| Abbott Laboratories | $155.77 | 8 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $132.90 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,655 | 93 | ABBVIE INC. ($271.15) |
| 2023 | $1,549 | 103 | PFIZER INC. ($389.27) |
| 2022 | $1,378 | 56 | ABBVIE INC. ($637.30) |
| 2021 | $2,045 | 96 | AbbVie Inc. ($731.06) |
| 2020 | $101.72 | 7 | GlaxoSmithKline, LLC. ($41.81) |
All Payment Transactions
355 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.81 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: DIABETES | ||||||
| 11/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Cardio-renal | ||||||
| 10/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: PSYCHIATRY | ||||||
| 10/18/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $10.99 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $1.86 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: DIABETES | ||||||
| 10/10/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $1.45 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/25/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $9.31 | General |
| Category: PAIN | ||||||
| 09/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Oncology | ||||||
| 09/17/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $15.27 | General |
| 09/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.20 | General |
| 09/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $33.31 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 536 | 704 | $129,171 | $50,888 |
| 2022 | 10 | 498 | 688 | $111,482 | $45,886 |
| 2021 | 9 | 426 | 586 | $89,111 | $38,836 |
| 2020 | 5 | 78 | 84 | $14,163 | $5,131 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 110 | 191 | $46,413 | $15,384 | 33.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 119 | 119 | $29,512 | $14,421 | 48.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 106 | 148 | $25,456 | $8,539 | 33.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 18 | 18 | $9,540 | $5,053 | 53.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 15 | 18 | $6,984 | $2,608 | 37.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 32 | 32 | $4,697 | $2,298 | 48.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 38 | 38 | $2,202 | $1,087 | 49.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 49 | 91 | $2,821 | $858.20 | 30.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 15 | 15 | $840.00 | $429.00 | 51.1% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 23 | 23 | $299.00 | $135.09 | 45.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 11 | $407.00 | $75.33 | 18.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 126 | 236 | $49,763 | $17,308 | 34.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 81 | 81 | $18,667 | $10,066 | 53.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 95 | 141 | $21,522 | $7,897 | 36.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 17 | 17 | $8,434 | $4,738 | 56.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 38 | 39 | $5,432 | $2,670 | 49.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 41 | 42 | $2,334 | $1,132 | 48.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 50 | 82 | $2,542 | $784.79 | 30.9% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 18 | 18 | $1,440 | $641.52 | 44.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 20 | 20 | $904.00 | $541.30 | 59.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 12 | $444.00 | $107.46 | 24.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 134 | 248 | $50,096 | $20,274 | 40.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 69 | 69 | $15,111 | $8,606 | 56.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 74 | 97 | $13,289 | $5,709 | 43.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $4,650 | $1,775 | 38.2% |
About Dr. Aaron Barnes, DO
Dr. Aaron Barnes, DO is a Family Medicine healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2017. The National Provider Identifier (NPI) number assigned to this provider is 1558892877.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aaron Barnes, DO has received a total of $6,727 in payments from pharmaceutical and medical device companies, with $1,655 received in 2024. These payments were reported across 355 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($6,727).
As a Medicare-enrolled provider, Barnes has provided services to 1,538 Medicare beneficiaries, totaling 2,062 services with total Medicare billing of $140,741. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Lexington, KY
- Active Since 03/27/2017
- Last Updated 07/04/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1558892877
Products in Payments
- UBRELVY (Drug) $831.93
- VRAYLAR (Drug) $830.21
- NURTEC ODT (Drug) $707.49
- MOUNJARO (Drug) $423.16
- JARDIANCE (Drug) $309.31
- QULIPTA (Drug) $299.66
- Ozempic (Drug) $261.00
- ELIQUIS (Drug) $238.50
- TRELEGY ELLIPTA (Drug) $235.18
- Wegovy (Drug) $175.70
- COMIRNATY (Biological) $147.06
- GARDASIL 9 (Biological) $99.91
- OFEV (Drug) $96.55
- VOQUEZNA (Drug) $95.30
- SHINGRIX (Biological) $92.26
- FARXIGA (Drug) $83.68
- ENTRESTO (Drug) $79.16
- FREESTYLE LIBRE 3 (Device) $77.79
- Rybelsus (Drug) $76.70
- TRINTELLIX (Drug) $72.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lexington
Dr. Keith Stokes, Md, MD
Family Medicine — Payments: $550,575
John Richard, Md, MD
Family Medicine — Payments: $438,915
Dr. Susan Neil, Md, MD
Family Medicine — Payments: $23,499
William Crigler, Md, MD
Family Medicine — Payments: $18,109
Dr. Mark Weiser, Md, MD
Family Medicine — Payments: $12,183
Dr. William Dacus, Md, MD
Family Medicine — Payments: $11,475